Carbamazepine
Drug
Apotex Inc.
Total Payments
$114,000
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $114,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $114,000 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| AED (antiepileptic drug) Pregnancy Registry | Apotex Inc. | $114,000 | 0 |
Top Doctors Receiving Payments for Carbamazepine
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $114,000 | 1 |
Ad
Manufacturing Companies
- Apotex Inc. $114,000
Product Information
- Type Drug
- Total Payments $114,000
- Total Doctors 0
- Transactions 1
About Carbamazepine
Carbamazepine is a drug associated with $114,000 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Apotex Inc..
Payment data is available from 2023 to 2023. In 2023, $114,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for Carbamazepine is "Unspecified" ($114,000, 100.0% of total).
Carbamazepine is associated with 1 research study, including "AED (antiepileptic drug) Pregnancy Registry" ($114,000).